Many women who suffered arterial events such as strokes or heart attacks have been waiting since 2009 for Bayer to come to the negotiating table. The women claim that Bayer’s oral contraceptives Yaz, Yasmin and Beyaz caused their injuries. Bayer has now agreed to set aside $56.9 million to compensate these women. It’s up to
New Plan for Handling Remaining Yaz Claims
Nearly 20,000 women have brought claims against Bayer for its failure to warn about Yaz’s association with increased risk of clotting. Women suffered deep vein thromboses, pulmonary embolis and death. Although Bayer has paid out approximately $1.7 billion in settlements to Yaz claimants approximately 3400 claims remain.
U.S. District Judge David Herndon expressed disappointment
Beyaz: Fortified Yaz
Beyaz is Bayer Healthcare Phamaceuticals’ newest birth control pill. In its latest marketing ploy, Bayer enriched its Yaz product. The new pill includes levomefolate calcium, which is designed to increase folate levels in women to help prevent neural tube birth defects. Neural tube birth defects include spina bifida and encephalopathy. 
Prevention of birth defects is
FDA Taking Another Look at Dangers of Yaz and Yasmin
The Food and Drug Administration approved Yaz and Yasmin based on research that Bayer provided saying that the drugs were safe. We’ve been saying all along that the research was suspect and that, in fact, the drug is more risky than other birth control pills with no added benefits. The danger, we said, was the
Civil Justice Group Reports on Yaz
Today a consumer rights group reports on the risks of blood clots, strokes, and heart attacks that Yaz and Yasmin pose to women using these birth control pills. The California-based group, called The Civil Justice Research Project, also reports on the the federal lawsuits that have been filed against Bayer by the hundreds of women who have suffered
Yaz and Yasmin Lawyers Team Up
We’re excited to report that The Danko Law Firm has teamed up with the Yaz lawyers at Girard Gibbs LLP in San Francisco to jointly represent the victims of Yaz and Yasmin in lawsuits against Bayer. Girard Gibbs is a nationally known class action firm with a long history of representing those harmed due to
FDA’s Role In Approving Yaz and Yasmin Examined
The legal talk show Lawyer2Lawyer invited Mike Danko and an FDA exp
ert, Professor James T. O’Reilly from the University of Cincinnati College of Law, to discuss Yaz and the Yaz lawsuits. Mike talked about the lawsuits while Professor O’Reilly provided his insights on what the FDA does and, more importantly, does not do when
Yaz Lawsuits Pile Up
The San Francisco Daily Journal has reported on the status of the Yaz litigation. The paper interviewed a number of Yaz lawyers, including Mike Danko. Susan Galinis spoke about her lawsuit:
I’m hoping to get the word out to other women about how dangerous that drug is. . It devastated my whole life.
As
Yaz and Yasmin: Drug Company Places Profits over Safety
The trendy Yaz and Yasmin birth control pills are unlike any others because they contain a new synthetic hormone, drospirenone. Bayer has aggressively marketed the drugs, especially to young 
women, as a cure for everything from acne to pre-menstrual syndrome. Unfortunately, Bayer did not adequately test the drug before bringing it to market, and
One Yaz Victim’s Story
I admire clients who find the strength to tell their stories on television. It takes guts. When Susan Galinis said she wanted to do just that, I warned her that it would be difficult and, well, embarassing. She said she didn’t care. If she could persuade just one woman to switch from Yaz to a